SREBP1, a crucial regulator of lipid accumulation and desaturation, undergoes symmetric dimethylation by PRMT5, thereby stabilizing it in clear-cell renal cell carcinoma [23]. Here, PRMT5 is linked to clear cell renal carcinoma.